AN2 Therapeutics Inc (ANTX)
2.56
+0.02
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
2.55
-0.01
(-0.39%)
After-Hours: 20:00
AN2 Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Gilead Sciences Inc | 0.00 |
QuidelOrtho Corp | 0.4824 |
CymaBay Therapeutics Inc (DELISTED) | 0.3735 |
Insmed Inc | -3.481 |
Revance Therapeutics Inc | -2.830 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 138.74M |
Total Liabilities (Quarterly) | 14.04M |
Shareholders Equity (Quarterly) | 124.70M |